Actinogen Medical is an ASX-listed biotechnology company developing innovative treatments for Alzheimer’s disease and the cognitive decline associated with neurodegenerative diseases and metabolic diseases, like Type 2 diabetes.
Actinogen Medical Ltd.
[stock_market_widget type=”leaderboard” template=”color-frame” color=”yellow” assets=”ACW.AX” api=”yf” style=”font-size: 15px”]
Management
Technology
Deals/Partnering
Research Pipeline
Funding
BioStartup's Score
0 / 50
KEY DETAILS
Websitehttps://actinogen.com.au
Disease Focus
Development Stage
STOCK CODEASX: ACW
AddressSuite 901, Level 9 109 Pitt Street, NSW 2000 SydneyAustralia
Suite 901, Level 9 109 Pitt Street, NSW 2000
Sydney
Australia
Contact Number+61 2 8964 7401
+61 2 8964 7401
[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=”https://www.linkedin.com/company/actinogen-medical” connections=”true” suffix=””]